Douros A - Search Results

1

Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study.

Abrahami D, Douros A, Yin H, Yu OH, Faillie JL, Montastruc F, Platt RW, Bouganim N, Azoulay L. Abrahami D, et al. Among authors: douros a. BMJ. 2018 Dec 5;363:k4880. doi: 10.1136/bmj.k4880. BMJ. 2018. PMID: 30518618 Free PMC article.

2

Drug-induced acute pancreatitis: results from the hospital-based Berlin case-control surveillance study of 102 cases.

Douros A, Bronder E, Andersohn F, Klimpel A, Thomae M, Ockenga J, Kreutz R, Garbe E. Douros A, et al. Aliment Pharmacol Ther. 2013 Oct;38(7):825-34. doi: 10.1111/apt.12461. Epub 2013 Aug 19. Aliment Pharmacol Ther. 2013. PMID: 23957710

3

Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events.

Douros A, Yin H, Yu OHY, Filion KB, Azoulay L, Suissa S. Douros A, et al. Diabetes Care. 2017 Nov;40(11):1506-1513. doi: 10.2337/dc17-0595. Epub 2017 Sep 1. Diabetes Care. 2017. PMID: 28864502

4

Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury.

Douros A, Azoulay L, Yin H, Suissa S, Renoux C. Douros A, et al. J Am Coll Cardiol. 2018 Mar 13;71(10):1105-1113. doi: 10.1016/j.jacc.2018.01.009. J Am Coll Cardiol. 2018. PMID: 29519351 Free article.

5

Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study.

Abrahami D, Douros A, Yin H, Yu OHY, Renoux C, Bitton A, Azoulay L. Abrahami D, et al. Among authors: douros a. BMJ. 2018 Mar 21;360:k872. doi: 10.1136/bmj.k872. BMJ. 2018. PMID: 29563098 Free PMC article.

6

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study.

Douros A, Dell'Aniello S, Yu OHY, Filion KB, Azoulay L, Suissa S. Douros A, et al. BMJ. 2018 Jul 18;362:k2693. doi: 10.1136/bmj.k2693. BMJ. 2018. PMID: 30021781 Free PMC article.

7

Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes.

Douros A, Abrahami D, Yin H, Yu OHY, Renoux C, Hudson M, Azoulay L. Douros A, et al. Epidemiology. 2018 Nov;29(6):904-912. doi: 10.1097/EDE.0000000000000891. Epidemiology. 2018. PMID: 30028343

8

Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy.

Douros A, Filion KB, Yin H, Yu OH, Etminan M, Udell JA, Azoulay L. Douros A, et al. Diabetes Care. 2018 Nov;41(11):2330-2338. doi: 10.2337/dc17-2280. Epub 2018 Aug 27. Diabetes Care. 2018. PMID: 30150234

9

What Fluoroquinolones Have the Highest Risk of Aortic Aneurysm? A Case/Non-case Study in VigiBase®.

Sommet A, Bénévent J, Rousseau V, Chebane L, Douros A, Montastruc JL, Montastruc F. Sommet A, et al. Among authors: douros a. J Gen Intern Med. 2019 Apr;34(4):502-503. doi: 10.1007/s11606-018-4774-2. J Gen Intern Med. 2019. PMID: 30565153 Free PMC article. No abstract available.

10

Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation.

Douros A, Renoux C, Yin H, Filion KB, Suissa S, Azoulay L. Douros A, et al. Am J Med. 2019 Feb;132(2):191-199.e12. doi: 10.1016/j.amjmed.2018.10.008. Epub 2018 Oct 25. Am J Med. 2019. PMID: 30691551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters